Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brouwer

Showing results (571-580 of 667) with videos related to

Pageof 67
Sort By:
NPJ Vaccines|December 4, 2021
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concernMitch Brinkkemper, Philip J M Brouwer, Pauline Maisonnasse, et al.
Scientific Reports|July 24, 2021
Genomic evolution of antimicrobial resistance in Escherichia coliPimlapas Leekitcharoenphon, Markus Hans Kristofer Johansson, Patrick Munk, et al.
The EMBO Journal|September 12, 2021
Infection and transmission of SARS-CoV-2 depend on heparan sulfate proteoglycansMarta Bermejo-Jambrina, Julia Eder, Tanja M Kaptein, et al.
Immunity|March 27, 2026
Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategiesAlexandra A Fischer, Martin Corcoran, Philip J M Brouwer, et al.
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Allergy|July 4, 2015
First successful reduction of clinical allergenicity of food by genetic modification: Mal d 1-silenced apples cause fewer allergy symptoms than the wild-type cultivarA E J Dubois, G Pagliarani, R M Brouwer, et al.
Cell Reports|May 20, 2023
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodiesHailee R Perrett, Philip J M Brouwer, Jonathan Hurtado, et al.
Biomedicines|February 25, 2023
New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 DiagnosisSabrina Mariotti, Maria Vincenza Chiantore, Raffaela Teloni, et al.
International Journal of Environmental Research and Public Health|August 7, 2021
Short and Long-Term Innovations on Dietary Behavior Assessment and Coaching: Present Efforts and Vision of the Pride and Prejudice ConsortiumDesiree A Lucassen, Marlou P Lasschuijt, Guido Camps, et al.
Molecular Cell|November 18, 2017
Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based DesignJason M Brouwer, Ping Lan, Angus D Cowan, et al.
Pageof 67

Showing results (571-580 of 667) with videos related to

Sort By:
Pageof 67
NPJ Vaccines|December 4, 2021
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concernMitch Brinkkemper, Philip J M Brouwer, Pauline Maisonnasse, et al.
Scientific Reports|July 24, 2021
Genomic evolution of antimicrobial resistance in Escherichia coliPimlapas Leekitcharoenphon, Markus Hans Kristofer Johansson, Patrick Munk, et al.
The EMBO Journal|September 12, 2021
Infection and transmission of SARS-CoV-2 depend on heparan sulfate proteoglycansMarta Bermejo-Jambrina, Julia Eder, Tanja M Kaptein, et al.
Immunity|March 27, 2026
Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategiesAlexandra A Fischer, Martin Corcoran, Philip J M Brouwer, et al.
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Allergy|July 4, 2015
First successful reduction of clinical allergenicity of food by genetic modification: Mal d 1-silenced apples cause fewer allergy symptoms than the wild-type cultivarA E J Dubois, G Pagliarani, R M Brouwer, et al.
Cell Reports|May 20, 2023
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodiesHailee R Perrett, Philip J M Brouwer, Jonathan Hurtado, et al.
Biomedicines|February 25, 2023
New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 DiagnosisSabrina Mariotti, Maria Vincenza Chiantore, Raffaela Teloni, et al.
International Journal of Environmental Research and Public Health|August 7, 2021
Short and Long-Term Innovations on Dietary Behavior Assessment and Coaching: Present Efforts and Vision of the Pride and Prejudice ConsortiumDesiree A Lucassen, Marlou P Lasschuijt, Guido Camps, et al.
Molecular Cell|November 18, 2017
Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based DesignJason M Brouwer, Ping Lan, Angus D Cowan, et al.
Pageof 67